Extrawell Pharmaceutical Holdings Limited (HKG:0858)
0.0930
+0.0420 (82.35%)
Jun 24, 2025, 3:44 PM HKT
HKG:0858 Cash Flow Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Net Income | 175.71 | -162.95 | 129.27 | 130.59 | -121.1 | 83.28 | Upgrade
|
Depreciation & Amortization | 8.61 | 9.05 | 8.8 | 8.73 | 8.12 | 6.36 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | - | 0.06 | - | -0.09 | Upgrade
|
Loss (Gain) From Sale of Investments | 132.93 | 132.93 | -158.66 | -168.64 | 104.7 | -101.38 | Upgrade
|
Loss (Gain) on Equity Investments | 2.28 | 2.28 | 3.85 | 3.65 | 2.88 | 3.17 | Upgrade
|
Provision & Write-off of Bad Debts | 0.09 | 0.09 | 0.8 | -0.27 | -2.73 | 5.92 | Upgrade
|
Other Operating Activities | -313.74 | 17.99 | 13.74 | 19.59 | 6.19 | 3.47 | Upgrade
|
Change in Accounts Receivable | 1.37 | 1.37 | 1 | 3.19 | 0.82 | 6.34 | Upgrade
|
Change in Inventory | -4.13 | -4.13 | 4.89 | -0.63 | -1.63 | -0.28 | Upgrade
|
Change in Accounts Payable | -1.83 | -1.83 | 0.18 | -0.24 | 0.45 | -1.89 | Upgrade
|
Change in Other Net Operating Assets | -2.97 | -2.97 | -3.53 | -0.14 | 1.44 | -18.16 | Upgrade
|
Operating Cash Flow | 2.81 | -3.69 | 1.18 | -1.77 | -0.85 | -13.25 | Upgrade
|
Capital Expenditures | -1.2 | -1.2 | -6.62 | -9.63 | -0.72 | -0.16 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | - | - | - | 0.09 | Upgrade
|
Investment in Securities | - | - | -5.88 | - | - | - | Upgrade
|
Other Investing Activities | 8.27 | 3.24 | 4.06 | 0.25 | 0.68 | -7.22 | Upgrade
|
Investing Cash Flow | 7.06 | 2.04 | -8.44 | -9.38 | -0.04 | -7.3 | Upgrade
|
Long-Term Debt Repaid | - | -1.32 | -2.3 | -1.8 | -1.69 | -0.21 | Upgrade
|
Net Debt Issued (Repaid) | -1.32 | -1.32 | -2.3 | -1.8 | -1.69 | -0.21 | Upgrade
|
Other Financing Activities | -5.16 | -5.18 | -0.09 | -0.14 | -0.21 | -0.03 | Upgrade
|
Financing Cash Flow | -6.48 | -6.5 | -2.39 | -1.94 | -1.9 | -0.24 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.92 | -0.64 | 0.16 | -1.75 | 3.07 | -1.67 | Upgrade
|
Net Cash Flow | 4.32 | -8.79 | -9.48 | -14.83 | 0.27 | -22.47 | Upgrade
|
Free Cash Flow | 1.61 | -4.89 | -5.44 | -11.39 | -1.57 | -13.41 | Upgrade
|
Free Cash Flow Margin | 2.69% | -8.28% | -7.49% | -15.41% | -2.00% | -17.29% | Upgrade
|
Free Cash Flow Per Share | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
Cash Interest Paid | 0.29 | 0.29 | 0.09 | 0.14 | 0.21 | 0.03 | Upgrade
|
Cash Income Tax Paid | 0.07 | 0.07 | 0.38 | 0.06 | 0.04 | -0.07 | Upgrade
|
Levered Free Cash Flow | 8.54 | -22.38 | -14.71 | -9.53 | -8.67 | -50.72 | Upgrade
|
Unlevered Free Cash Flow | 21.3 | -10.63 | -4.94 | -1.26 | -1.64 | -44.88 | Upgrade
|
Change in Net Working Capital | -17.81 | 14.37 | 0.07 | -7.73 | 2.25 | 46.02 | Upgrade
|
Updated Dec 17, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.